scispace - formally typeset
A

Arezou A. Ghazani

Researcher at Harvard University

Publications -  33
Citations -  6864

Arezou A. Ghazani is an academic researcher from Harvard University. The author has contributed to research in topics: Germline & Germline mutation. The author has an hindex of 18, co-authored 29 publications receiving 6154 citations. Previous affiliations of Arezou A. Ghazani include Ontario Institute for Cancer Research & University of Toronto.

Papers
More filters
Journal ArticleDOI

Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.

TL;DR: The intracellular uptake of different sized and shaped colloidal gold nanoparticles is investigated and it is shown that kinetics and saturation concentrations are highly dependent upon the physical dimensions of the nanoparticles.
Journal ArticleDOI

Assessing the Effect of Surface Chemistry on Gold Nanorod Uptake, Toxicity, and Gene Expression in Mammalian Cells

TL;DR: Results indicate that gold nanorods are well suited for therapeutic applications, such as thermal cancer therapy, due to their tunable cell uptake and low toxicity.
Journal ArticleDOI

Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium

TL;DR: Although an initial pilot of the ACMG-AMP guidelines did not lead to increased concordance in variant interpretation, comparing variant interpretations to identify differences and having a common framework to facilitate resolution of those differences were beneficial for improving agreement, allowing iterative movement toward increased reporting consistency for variants in genes associated with monogenic disease.
Journal ArticleDOI

Ultrasensitive Clinical Enumeration of Rare Cells ex Vivo Using a Micro-Hall Detector

TL;DR: A miniature device that combines microfluidics and magnets to measure CTCs in patient blood at single-cell resolution and appears to be a more sensitive cell counter than existing devices, with the potential to change patient management and disease monitoring in the clinic.
Journal ArticleDOI

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine

Andrew J. Aguirre, +89 more
- 14 Jun 2018 - 
TL;DR: Using an integrated multidisciplinary biopsy program, it is demonstrated that real-time genomic characterization of advanced PDAC can identify clinically relevant alterations that inform management of this difficult disease.